Clinical trial · Observational
Pediatric Normative Markerless Movement Analysis
Pediatric Normative Markerless Movement Analysis Data Collection Project
NCT06249880CI-TRIAL-00105052recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this project is to collect baseline data from a normative population of 20 children that gender and age matches the population of patients expected to be treated by Mary Bridge Children's Research \& Movement Lab.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adolescent | — | UNRESOLVED | — |
| Pediatric ALL | Childhood Acute Lymphoblastic Leukemia | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Observation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Normative
- description
- 40 neurotypical pediatric subjects
- interventionNames
- Other: Observation
Primary outcomes (1)
- measure
- Observation-based movement analyses
- timeFrame
- Baseline
- description
- The purpose of this normative data collection study is to collect baseline data from a normative population of children/adolescents using force plates and 3D markerless motion capture. Together these are used to calculate a normative range of body position and joint angles (kinematics), as well as joint loads and ground reaction forces (kinetics) during prescribed activities.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 3 Years
- Maximum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Age: 3-25 years of age (with 3 and 25 year olds considered for inclusion). * Ambulate independently and without the use of assistive devices or orthoses. * Willing and interested in participating. Exclusion Criteria: * Neuromuscular disorders such as cerebral palsy, muscular dystrophy, myotonic dystrophy, spinal muscular atrophy, peripheral neuropathy, or other generalized muscle and/or nerve issues. * Evidence of developmental delays, muscle weakness, decreased muscle tone, joint stiffness, muscle or bone deformity. * Currently using or has a history of using assistive technology devices, bracing/orthoses, manual or powered mobility equipment. * History of premature birth. * Currently or has a history of taking medication or pharmaceutical treatment related to musculoskeletal side-effects/scenario/diagnosis.
References
Publications (0)
Data not yet available
No reference posted for this study.